Skip to main content
Aaron Nagiel, MD, Ophthalmology, Ventura, CA

Aaron Nagiel MD


Physician

Join to View Full Profile
  • 300 Hillmont Ave Building 340 Ste 302Ventura, CA 93003

  • Phone+1 805-652-6255

  • Fax+1 323-361-7993

Dr. Nagiel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
    UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2012 - 2015
  • UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
    UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2011 - 2014
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2011 - 2012
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2027
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Let’s Talk About Gene Therapy for Inherited Retinal Diseases
    Let’s Talk About Gene Therapy for Inherited Retinal DiseasesAugust 11th, 2021
  • The Differential Diagnosis of Central Serous Chorioretinopathy and Other Diseases Associated with Subretinal Fluid in the Macula
    The Differential Diagnosis of Central Serous Chorioretinopathy and Other Diseases Associated with Subretinal Fluid in the MaculaMarch 11th, 2021
  • SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and More
    SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and MoreOctober 1st, 2019
  • Join now to see all

Grant Support

  • Development and Maintenance of the Human Photoreceptor-Bipolar Cell Synapse.CHILDREN'S HOSPITAL OF LOS ANGELES2020–2025
  • Specificity Of Neuronal Connections In The Zebrafish Lateral LINENational Institute Of Neurological Disorders And Stroke2008–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: